Skip to content

VÉTOQUINOL

Active
Public limited companyfounded 196858 yrs activeGalileilaan 11, 2845 Niel, BelgiumKBO/BCE: BE 0403.086.072
Summary

The computed 12-month bankruptcy probability of VÉTOQUINOL is 5.3% (elevated). The 2023 annual accounts show equity of €280,006 and a net result of €527,980. Equity is shrinking by ~3.5% per year across the filed fiscal years. The company has been active since 1968 and the Belgian State Gazette contains no insolvency or warning signals.

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460NACE 51460
1 site
Size
€16.8mturnover 2023
Staff
34.9 FTE
Equity
€280,006
Profit
€527,980
Financial health
Bankruptcy chance 12 m
5.3%
2023 figures too old to score
Structure
Parent
Vétoquinol SA
Accounts 66 d overdue0 of 14 deeds read
Signals- Figures for FY 2023 (filed 16-07-2024)- Liquidity: current ratio 1.02- 1 financial year not filed after the legal deadline; latest accounts 89 days late; 2 of the last 3 late- Equity €280,006 (5.4% of total assets)Filed after the deadlineShow the evidence

Checked score

No current score
Figures too old
The available figures for FY 2023 are too old to assess current financial health.
Bankruptcy probability: Elevated
Financial strength, FY 2023 · tick = 2022
Weak
Solvency 30=
equity 5.4% of total assets
Liquidity 0=
short-term debt 93.8%
Profitability 69+7
return on assets 10.2%
Bankruptcy probability, 12 months
5.3% Elevated
0%0.5%1.5%4%10%≥ 25%

About 5 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (4,378 companies)
Last 24 months 11-2024: 1.1% 12-2024: 1.1%● 0.0% vs 11-2024 01-2025: 1.1%● 0.0% vs 12-2024 02-2025: 1.1%▼ -1.6% vs 01-2025 03-2025: 1.1%▼ -0.8% vs 02-2025 04-2025: 1.0%▼ -2.2% vs 03-2025lowest value 05-2025: 1.0%● 0.0% vs 04-2025lowest value 06-2025: 1.1%▲ +2.6% vs 05-2025 07-2025: 1.3%▲ +22.3% vs 06-2025 08-2025: 1.8%▲ +40.1% vs 07-2025 09-2025: 2.1%▲ +16.2% vs 08-2025 10-2025: 2.9%▲ +38.7% vs 09-2025 11-2025: 3.0%▲ +1.9% vs 10-2025 12-2025: 3.1%▲ +3.0% vs 11-2025 01-2026: 5.1%▲ +64.5% vs 12-2025 02-2026: 5.1%● 0.0% vs 01-2026 03-2026: 5.1%● 0.0% vs 02-2026 04-2026: 4.6%▼ -9.4% vs 03-2026 05-2026: 4.6%● 0.0% vs 04-2026 06-2026: 4.6%● 0.0% vs 05-2026 07-2026: 4.6%● 0.0% vs 06-2026 08-2026: 5.3%▲ +16.6% vs 07-2026highest value 09-2026: 5.3%● 0.0% vs 08-2026highest value 10-2026: 5.3%● 0.0% vs 09-2026highest value
  • Figures for FY 2023 (filed 16-07-2024) raises the probability
  • Liquidity: current ratio 1.02 raises the probability
  • 1 financial year not filed after the legal deadline; latest accounts 89 days late; 2 of the last 3 late raises the probability
  • Equity €280,006 (5.4% of total assets) raises the probability
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Figures for FY 2023 (filed 16-07-2024)
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · Liquidity: current ratio 1.02
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · 1 financial year not filed after the legal deadline; latest accounts 89 days late; 2 of the last 3 late
In the bankruptcy model this factor raises the probability.
NBB · filings
raises risk · Equity €280,006 (5.4% of total assets)
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 28-10-2025, 89 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
89 d late
2023
22 d early
2022
107 d late
2021
68 d late
2020
34 d late
2019
42 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 53 days after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2024 · full…
  2. Annual accounts filedfiscal year 2023 · full…
  3. Annual accounts filedfiscal year 2022 · full…

Key points

  • Positive: Result rose in 2023from €251,391 to €527,980 ▲ 110% View
  • Caution: Accounts not fileddeadline was 31-07-2026 66 d late View
  • Controlled by Vétoquinol SA parent View
  • Active since 1968founded 01-01-1968 58 years View
  • Positive: 6 profitable years in a rowprofit 2023: €527,980 6 years View

By topic

Financials

Fiscal year
2023
Turnover
€16.8m
Profit
€527,980
Solvency
5.4%
Turnover▲ 3.4%
Net result
20182023
Go to Financials

Timeline

Events
12
Since
2016
  1. 28-10-2025Annual accounts filed
  2. 09-07-2024Annual accounts filed
  3. 15-11-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
01-01-1968
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.